应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
PODD 银休特
盘前交易 11-09 08:40:06 EST
146.51
-9.61
-6.16%
盘前
147.60
+1.09
+0.74%
08:33 EST
最高
155.60
最低
143.28
成交量
156.81万
今开
155.60
昨收
156.12
日振幅
7.89%
总市值
101.48亿
流通市值
101.20亿
总股本
6,926万
成交额
2.29亿
换手率
2.27%
流通股本
6,907万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读|银休特盘中下跌5.84%,业绩利好兑现后估值消化加剧
行情直击 · 11-06 23:03
异动解读|银休特盘中下跌5.84%,业绩利好兑现后估值消化加剧
异动解读|银休特盘中下跌5.16%,股价冲高后遭获利了结
行情直击 · 11-06
异动解读|银休特盘中下跌5.16%,股价冲高后遭获利了结
异动解读|银休特盘中上涨5.25%,三季度业绩超预期并启动10亿美元回购
行情直击 · 11-05
异动解读|银休特盘中上涨5.25%,三季度业绩超预期并启动10亿美元回购
异动解读|银休特盘中上涨5.06%,报146.775美元
行情直击 · 08-19
异动解读|银休特盘中上涨5.06%,报146.775美元
银休特遭Leerink Partners降级:从“跑赢大盘”调至“市场表现”,目标价从247美元大砍至145美元
美股速递 · 08-06
银休特遭Leerink Partners降级:从“跑赢大盘”调至“市场表现”,目标价从247美元大砍至145美元
异动解读|银休特盘中下跌23.5%,业绩超预期但全年指引下调引发抛售
行情直击 · 08-05
异动解读|银休特盘中下跌23.5%,业绩超预期但全年指引下调引发抛售
异动解读 | 财报发布引发市场担忧,银休特盘前大跌13.08%
异动解读 · 08-05
异动解读 | 财报发布引发市场担忧,银休特盘前大跌13.08%
异动解读|银休特盘前下跌11.46%,财报发布日股价大幅承压
行情直击 · 08-05
异动解读|银休特盘前下跌11.46%,财报发布日股价大幅承压
财报前瞻 |银休特本季度营收预计增28.59%,机构观点偏多
财报Agent · 07-29
财报前瞻 |银休特本季度营收预计增28.59%,机构观点偏多
Insulet(PODD)无导管胰岛素泵技术Omnipod® 5与Omnipod Discover™ 进军西班牙市场
金吾财讯 · 07-06
Insulet(PODD)无导管胰岛素泵技术Omnipod® 5与Omnipod Discover™ 进军西班牙市场
异动解读|银休特盘中下跌5.12%,FDA发布胰岛素泵高风险早期预警
行情直击 · 06-11
异动解读|银休特盘中下跌5.12%,FDA发布胰岛素泵高风险早期预警
FDA发布早期预警:银休特胰岛素泵存在潜在高风险问题
美股速递 · 06-05
FDA发布早期预警:银休特胰岛素泵存在潜在高风险问题
银休特宣布在美国推出升级版Omnipod® 5算法,并扩展与雅培Freestyle Libre 3 Plus传感器的兼容性
美股速递 · 06-03
银休特宣布在美国推出升级版Omnipod® 5算法,并扩展与雅培Freestyle Libre 3 Plus传感器的兼容性
异动解读|银休特盘中下跌6.74%,启动Omnipod产品自愿纠正行动并预计承担最高5000万美元成本
行情直击 · 05-28
异动解读|银休特盘中下跌6.74%,启动Omnipod产品自愿纠正行动并预计承担最高5000万美元成本
银休特公司预计2026年因设备纠正产生最高5000万美元成本,调整后业绩将予剔除
美股速递 · 05-27
银休特公司预计2026年因设备纠正产生最高5000万美元成本,调整后业绩将予剔除
银休特公司:预计发货、产品供应及新客户启动均无中断风险——SEC文件披露
美股速递 · 05-27
银休特公司:预计发货、产品供应及新客户启动均无中断风险——SEC文件披露
银休特在美国及受影响的国际市场主动对特定Omnipod® Pods发起医疗器械纠正行动
美股速递 · 05-27
银休特在美国及受影响的国际市场主动对特定Omnipod® Pods发起医疗器械纠正行动
银休特盘中异动 早盘大幅跳水5.00%报239.22美元
市场透视 · 2025-03-10
银休特盘中异动 早盘大幅跳水5.00%报239.22美元
银休特盘中异动 大幅跳水5.17%报268.83美元
市场透视 · 2025-02-25
银休特盘中异动 大幅跳水5.17%报268.83美元
银休特2024财年实现净利润4.18亿美元,同比增加102.91%
市场透视 · 2025-02-24
银休特2024财年实现净利润4.18亿美元,同比增加102.91%
加载更多
公司概况
公司名称:
银休特
所属市场:
NASDAQ
上市日期:
--
主营业务:
Insulet Corporation是于2000年成立的一家特拉华州的公司。该公司主要从事开发、制造和销售其专有的胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。Omnipod平台包括:Omnipod 5自动胰岛素输送系统、Omnipod DASH胰岛素管理系统、Omnipod胰岛素管理系统和最新创新产品Omnipod GOTM,于2023年获得美国食品和药物管理局的许可。该公司还为安进生产Pods,用于Neulasta Onpro试剂盒,这是一种用于安进的Neulasta的递送系统,可帮助降低密集化疗后的感染风险。
发行价格:
--
{"stockData":{"symbol":"PODD","market":"US","secType":"STK","nameCN":"银休特","latestPrice":146.51,"timestamp":1793998800000,"preClose":156.12,"halted":0,"volume":1568052,"hourTrading":{"tag":"盘前","latestPrice":147.6,"preClose":146.51,"latestTime":"08:33 EST","volume":5198,"amount":765846.4983200001,"timestamp":1794231237471,"change":1.09,"changeRate":0.00744,"amplitude":0.012218},"delay":0,"changeRate":-0.0615552139379965,"floatShares":69074286,"shares":69263700,"eps":6.12,"marketStatus":"盘前交易","change":-9.61,"latestTime":"11-09 08:40:06 EST","open":155.6,"high":155.6,"low":143.282,"amount":229041843.20352,"amplitude":0.078901,"askPrice":147.72,"askSize":13,"bidPrice":146.51,"bidSize":50,"shortable":3,"etf":0,"ttmEps":6.12,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794234600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1179201600000,"exchange":"NASDAQ","adjPreClose":146.51,"preHourTrading":{"tag":"盘前","latestPrice":147.6,"preClose":146.51,"latestTime":"08:33 EST","volume":5198,"amount":765846.4983200001,"timestamp":1794231237471,"change":1.09,"changeRate":0.00744,"amplitude":0.012218},"postHourTrading":{"tag":"盘后","latestPrice":146.86,"preClose":146.51,"latestTime":"19:58 EST","volume":37427,"amount":5466096.4692,"timestamp":1794013111372,"change":0.35,"changeRate":0.002389,"amplitude":0.019521},"volumeRatio":0.9327817585641771,"impliedVol":0.5894,"impliedVolPercentile":0.844},"requestUrl":"/m/hq/s/PODD","defaultTab":"news","newsList":[{"id":"1117002450","title":"异动解读|银休特盘中下跌5.84%,业绩利好兑现后估值消化加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=1117002450","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117002450?lang=zh_cn&edition=full","pubTime":"2026-11-06 23:03","pubTimestamp":1793977403,"startTime":"0","endTime":"0","summary":"11月6日,银休特盘中下跌5.84%,报146.995美元,成交额1922.54万美元。消息面上,公司此前披露三季度调整后每股收益1.99美元、营收8.42亿美元,均高于市场预期,并维持全年调整后每股收益增长超30%的展望,同时获批10亿美元回购计划。不过,在业绩利好兑现后,市场交易重心转向估值消化。最新动态显示,有机构虽上调目标价至167美元,但相较市场一致预期均值仍偏谨慎,叠加前一交易日股价已因财报上冲,短线获利了结压力释放,推动股价回落。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"业绩超预期却回落,银休特估值承压","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171580564","title":"异动解读|银休特盘中下跌5.16%,股价冲高后遭获利了结","url":"https://stock-news.laohu8.com/highlight/detail?id=1171580564","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171580564?lang=zh_cn&edition=full","pubTime":"2026-11-06 00:25","pubTimestamp":1793895915,"startTime":"0","endTime":"0","summary":"11月6日,银休特盘中下跌5.16%,报156.5051美元,成交额5307.3万美元。消息面上,公司此前披露三季度调整后每股收益1.99美元,高于市场预期的1.59美元,营收8.42亿美元,也高于预期的8.326亿美元,并维持全年调整后每股收益增长超30%的展望,同时获批10亿美元回购计划。不过,最新动态显示,Leerink Partners虽将目标价由143美元上调至167美元,但相较当前一致预期均值177.33美元仍偏谨慎;在业绩利好兑现后,市场交易重心转向估值消化,股价出现回落。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"财报超预期后回落,银休特遭获利了结","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101718439","title":"异动解读|银休特盘中上涨5.25%,三季度业绩超预期并启动10亿美元回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1101718439","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101718439?lang=zh_cn&edition=full","pubTime":"2026-11-05 00:24","pubTimestamp":1793809486,"startTime":"0","endTime":"0","summary":"11月5日,银休特盘中上涨5.25%,报162.22美元,成交额1.32亿美元。驱动消息来自最新季度业绩。公司三季度调整后每股收益1.99美元,高于市场预期的1.59美元,也高于上年同期的1.24美元;营收8.42亿美元,同比增长至高于预期的8.326亿美元。同时,公司维持全年调整后每股收益增长超30%的展望,并获董事会批准10亿美元股票回购计划,预计第四季度先行回购约4亿美元,显示其现金实力与资本配置信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"银休特业绩超预期,回购计划助力上涨","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115824455","title":"异动解读|银休特盘中上涨5.06%,报146.775美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1115824455","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1115824455?lang=zh_cn&edition=full","pubTime":"2026-08-19 01:37","pubTimestamp":1787074656,"startTime":"0","endTime":"0","summary":"8月19日,银休特盘中上涨5.06%,报146.775美元/股,成交额9627.31万美元。银休特所在的医疗保健设备行业中,个股中,史赛克涨1.17%,Profusa Inc涨160.49%,直觉外科公司涨1.67%,波士顿科学跌0.49%,雅培涨2.22%。银休特主要从事开发、制造和销售其专有的Omnipod胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者管理,核心产品包括Omnipod 5自动胰岛素输送系统等。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194413546","title":"银休特遭Leerink Partners降级:从“跑赢大盘”调至“市场表现”,目标价从247美元大砍至145美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194413546","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194413546?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:08","pubTimestamp":1786014491,"startTime":"0","endTime":"0","summary":"Leerink Partners下调了银休特(Insulet Corporation)的股票评级,由“跑赢大盘”(Outperform)降至“市场表现”(Market Perform)。与此同时,该机构还将这家公司的目标股价从247美元大幅削减至145美元。这一调整折射出市场对银休特未来增长前景的重新评估,降级幅度之大,令人瞩目。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4551","BK4588","LU0728928796.USD","LU2065169927.USD","LU2065170008.USD","PODD","LU1119994496.HKD","LU2324357040.USD","LU1261432733.SGD","LU2065171402.SGD","LU2065171311.SGD","LU1084165304.USD","BK4082","BK4566","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144673368","title":"异动解读|银休特盘中下跌23.5%,业绩超预期但全年指引下调引发抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=1144673368","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1144673368?lang=zh_cn&edition=full","pubTime":"2026-08-05 21:32","pubTimestamp":1785936720,"startTime":"0","endTime":"0","summary":"8月5日,银休特盘中下跌23.5%,报128.14美元/股,成交额5773.57万美元。消息面上,公司于当日盘前发布第二季度财报。然而,公司同步下调全年营收指引,市场对增长前景的担忧压倒了短期业绩利好,引发大幅抛售。此外,公司此前因制造缺陷对部分Omnipod产品发起自愿医疗器械纠正,FDA亦就其胰岛素泵发布潜在高风险早期预警,监管压力持续悬于估值之上。银休特主要从事Omnipod胰岛素持续递送系统的开发、制造和销售,服务于胰岛素依赖型糖尿病患者。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"银休特盘中下跌23.5%,业绩超预期但全年指引下调引发抛售","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114187098","title":"异动解读 | 财报发布引发市场担忧,银休特盘前大跌13.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=1114187098","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114187098?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:12","pubTimestamp":1785928342,"startTime":"0","endTime":"0","summary":"银休特(PODD)今日盘前股价大跌13.08%,引发市场广泛关注。消息面上,公司于盘前发布了第二季度财报。此前市场一致预期本季度营收7.87亿美元,同比增长28.59%,调整后每股收益1.45美元,同比增长56.42%。上季度公司业绩曾超预期,但此次盘前股价大幅回落,表明市场对本次业绩或前瞻指引反应消极。此外,FDA此前曾就公司胰岛素泵产品发布潜在高风险早期预警,监管压力仍为市场持续关注的因素。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179489690","title":"异动解读|银休特盘前下跌11.46%,财报发布日股价大幅承压","url":"https://stock-news.laohu8.com/highlight/detail?id=1179489690","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1179489690?lang=zh_cn&edition=full","pubTime":"2026-08-05 19:10","pubTimestamp":1785928203,"startTime":"0","endTime":"0","summary":"8月5日,银休特盘前下跌11.46%,报147.925美元/股,成交额57.93万美元。消息面上,公司于当日盘前发布第二季度财报。此前市场一致预期本季度营收7.87亿美元(同比增28.59%),调整后每股收益1.45美元(同比增56.42%)。上季度公司业绩曾超预期,调整后EPS为1.55美元超预期6.6%,营收亦超市场预估。当前股价盘前大幅回落,表明市场对本次业绩或前瞻指引反应消极。此外,FDA此前曾就公司胰岛素泵产品发布潜在高风险早期预警,监管压力仍为市场关注因素。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165064727","title":"财报前瞻 |银休特本季度营收预计增28.59%,机构观点偏多","url":"https://stock-news.laohu8.com/highlight/detail?id=1165064727","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165064727?lang=zh_cn&edition=full","pubTime":"2026-07-29 10:18","pubTimestamp":1785291517,"startTime":"0","endTime":"0","summary":"银休特将于2026年08月05日美股盘前发布财报,市场聚焦营收、利润与监管事件的影响消化进度。市场一致预期显示,本季度银休特营收为7.87亿美元,同比增长28.59%;调整后每股收益为1.45美元,同比增长56.42%;EBIT为1.39亿美元,同比增长49.58%;当前未见一致口径的毛利率及净利润或净利率预测数据。上季度银休特营收7.62亿美元,同比增长33.87%;毛利率69.45%;归属于母公司股东的净利润为9,110.00万美元;净利率11.96%;调整后每股收益1.42美元,同比增长40.59%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻 |银休特本季度营收预计增28.59%,机构观点偏多","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649298916","title":"Insulet(PODD)无导管胰岛素泵技术Omnipod® 5与Omnipod Discover™ 进军西班牙市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2649298916","media":"金吾财讯","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649298916?lang=zh_cn&edition=full","pubTime":"2026-07-06 19:37","pubTimestamp":1783337849,"startTime":"0","endTime":"0","summary":"金吾财讯 | 全球无导管胰岛素泵技术的创新领军企业 Insulet Corporation 宣布,其旗舰产品 Omnipod 5 自动胰岛素输注系统以及专有的回顾性数据分析与报告平台 Omnipod Discover 正式引入西班牙。此举标志着西班牙成为 Insulet 销往 Omnipod 产品的全球第26个国家,同时也是 Omnipod 5 落地上市的第20个国家。在过去的18个月里,Insulet 已相继在15个国家推出了该系统,显示出其强劲的国际化增长势头。Insulet 高级副总裁兼国际总经理帕特·克兰内尔表示,西班牙是一个重要且充满活力的市场。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250107/ZWU5OWQwM2E0MjY1ODI1NjNmZDJjN2ZmZWQ3OTIxNzAyOTY4MjgwNQ==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZWU5OWQwM2E0MjY1ODI1NjNmZDJjN2ZmZWQ3OTIxNzAyOTY4MjgwNQ==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"302217","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU0728928796.USD","LU2065169927.USD","LU2065171402.SGD","BK4082","BK4585","BK4588","LU1261432733.SGD","BK4551","EWP","LU1119994496.HKD","PODD","LU2065170008.USD","LU2065171311.SGD","LU1084165304.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193198827","title":"异动解读|银休特盘中下跌5.12%,FDA发布胰岛素泵高风险早期预警","url":"https://stock-news.laohu8.com/highlight/detail?id=1193198827","media":"行情直击","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1193198827?lang=zh_cn&edition=full","pubTime":"2026-06-11 02:39","pubTimestamp":1781116771,"startTime":"0","endTime":"0","summary":"6月11日,银休特盘中下跌5.12%,报151.44美元/股,成交额9466.64万美元。消息面上,美国食品药品监督管理局(FDA)设备与放射健康中心此前发布早期预警,通报银休特公司胰岛素泵产品可能存在潜在高风险问题。胰岛素泵为银休特核心产品线,FDA安全警告直接冲击市场对其产品合规性及后续销售前景的信心。银休特所在的医疗保健设备行业整体承压,个股中,雅培跌2.48%,波士顿科学跌1.85%,直觉外科公司跌2.67%,史赛克跌1.63%,美敦力跌1.95%。(以上内容均基于市场公开消息,由程序或算法智能生成,仅作为股价异动提醒,不作为投资建议或交易依据。)","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1178421196","title":"FDA发布早期预警:银休特胰岛素泵存在潜在高风险问题","url":"https://stock-news.laohu8.com/highlight/detail?id=1178421196","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1178421196?lang=zh_cn&edition=full","pubTime":"2026-06-05 02:26","pubTimestamp":1780597572,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)设备与放射健康中心(CDRH)发布了一项早期预警,旨在向公众通报银休特公司胰岛素泵产品可能存在的潜在高风险问题。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","PODD","LU0728928796.USD","LU1261432733.SGD","BK4585","BK4566","LU2065171311.SGD","LU2065170008.USD","BK4588","LU1084165304.USD","BK4082","LU2065171402.SGD","BK4551","LU1119994496.HKD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154417169","title":"银休特宣布在美国推出升级版Omnipod® 5算法,并扩展与雅培Freestyle Libre 3 Plus传感器的兼容性","url":"https://stock-news.laohu8.com/highlight/detail?id=1154417169","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154417169?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:01","pubTimestamp":1780484483,"startTime":"0","endTime":"0","summary":"银休特公司宣布,其升级版Omnipod® 5算法已在美国市场正式推出,同时进一步扩展了与雅培公司Freestyle Libre 3 Plus传感器的兼容性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU1023059063.AUD","BK4533","IE00B4R5TH58.HKD","LU2112291526.USD","IE00BFTCPJ56.SGD","BK4581","SG9999002224.SGD","SG9999002232.USD","LU1721429741.USD","LU1261432733.SGD","IE00BJJMRZ35.SGD","BK4588","LU0122379950.USD","BK4585","IE0002141913.USD","IE0009355771.USD","LU2065171311.SGD","BK4504","LU0728928796.USD","LU0114720955.EUR","BK4566","LU2237957902.USD","LU1721429402.USD","BK4551","LU1061106388.HKD","LU2211815571.USD","BK4592","SG9999004303.SGD","LU1914381329.SGD","LU1084165304.USD","SGXZ41872573.SGD","BK4082","LU0882574055.USD","LU1691799644.USD","LU1057294990.SGD","LU2065169927.USD","LU2237957811.SGD","SGXZ23171101.USD","LU0058720904.USD","IE00B2B36J28.USD","ABT","LU2065170008.USD","LU2089984988.USD","LU1119994496.HKD","LU0234572021.USD","LU0289739699.SGD","LU0170899867.USD","LU2468319806.SGD","LU2324357040.USD","LU1989763427.SGD","LU2065171402.SGD","LU1989763690.USD","LU0266013472.USD","LU2133065610.SGD","BK4568","LU0868494617.USD","PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1113809635","title":"异动解读|银休特盘中下跌6.74%,启动Omnipod产品自愿纠正行动并预计承担最高5000万美元成本","url":"https://stock-news.laohu8.com/highlight/detail?id=1113809635","media":"行情直击","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1113809635?lang=zh_cn&edition=full","pubTime":"2026-05-28 00:15","pubTimestamp":1779898538,"startTime":"0","endTime":"0","summary":"5月28日,银休特盘中下跌6.74%,报143.44美元/股,成交额1.57亿美元。消息面上,公司宣布在美国及受影响的国际市场对特定批次Omnipod 5、Omnipod DASH及Omnipod胰岛素管理系统Pods发起自愿性医疗器械纠正行动。公司预计因此将产生最高5000万美元成本,该费用将不计入调整后业绩,同时维持全年业绩指引不变。此外,高盛将银休特目标价从237美元下调至205美元,维持买入评级。银休特主要从事开发、制造和销售专有胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197186613","title":"银休特公司预计2026年因设备纠正产生最高5000万美元成本,调整后业绩将予剔除","url":"https://stock-news.laohu8.com/highlight/detail?id=1197186613","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197186613?lang=zh_cn&edition=full","pubTime":"2026-05-27 04:09","pubTimestamp":1779826154,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会提交的文件,医疗设备制造商银休特公司披露,预计在2026年将产生最高达5000万美元的成本,该笔支出与其设备纠正措施相关,且将不计入公司的调整后业绩结果中。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065170008.USD","BK4551","PODD","BK4588","LU2324357040.USD","LU0728928796.USD","BK4585","BK4566","LU2065171402.SGD","LU2065171311.SGD","LU1084165304.USD","LU2065169927.USD","BK4082","LU1261432733.SGD","LU1119994496.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126626549","title":"银休特公司:预计发货、产品供应及新客户启动均无中断风险——SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1126626549","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126626549?lang=zh_cn&edition=full","pubTime":"2026-05-27 04:09","pubTimestamp":1779826152,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会提交的文件,银休特公司表示,预计其产品发货、产品供应以及新客户启动服务均不会受到任何干扰。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1084165304.USD","LU0728928796.USD","LU2324357040.USD","PODD","LU1261432733.SGD","LU2065171311.SGD","BK4082","LU2065169927.USD","BK4566","LU2065170008.USD","BK4551","LU2065171402.SGD","BK4585","BK4588","LU1119994496.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171171876","title":"银休特在美国及受影响的国际市场主动对特定Omnipod® Pods发起医疗器械纠正行动","url":"https://stock-news.laohu8.com/highlight/detail?id=1171171876","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171171876?lang=zh_cn&edition=full","pubTime":"2026-05-27 04:06","pubTimestamp":1779825998,"startTime":"0","endTime":"0","summary":"银休特公司已在美国及受影响的国际市场启动一项自愿性医疗器械纠正行动,针对特定批次的Omnipod® Pods产品。此次行动旨在主动解决潜在的产品问题,确保患者安全与设备可靠性符合最高标准。公司正与相关监管机构密切合作,并直接联系受影响的用户及医疗机构,提供明确的指导与后续步骤。银休特强调,其对产品质量和用户健康的承诺始终是首要任务,并将持续透明地通报进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU1119994496.HKD","PODD","LU0728928796.USD","BK4566","LU2065171311.SGD","LU2324357040.USD","LU1084165304.USD","LU2065171402.SGD","LU1261432733.SGD","BK4551","LU2065170008.USD","BK4585","LU2065169927.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518127466","title":"银休特盘中异动 早盘大幅跳水5.00%报239.22美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518127466","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518127466?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:46","pubTimestamp":1741614369,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时46分,银休特股票出现异动,股价快速下挫5.00%。截至发稿,该股报239.22美元/股,成交量7.0932万股,换手率0.10%,振幅3.93%。银休特股票所在的医疗器械行业中,整体跌幅为0.88%。银休特公司简介:Insulet成立于2000年,公司的目标是使持续皮下胰岛素输液疗法治疗糖尿病更加容易。自从Omnipod于2005年被美国食品和药物管理局批准以来,全世界大约有425,000名胰岛素依赖型糖尿病患者正在使用Omnipod产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214609abf301e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310214609abf301e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4566","LU1261432733.SGD","PODD","LU0728928796.USD","BK4082","BK4588","LU1119994496.HKD","LU2324357040.USD","BK4551","BK4585","LU1084165304.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514138160","title":"银休特盘中异动 大幅跳水5.17%报268.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514138160","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514138160?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:04","pubTimestamp":1740495874,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时04分,银休特股票出现波动,股价急速跳水5.17%。截至发稿,该股报268.83美元/股,成交量20.2547万股,换手率0.29%,振幅4.83%。最近的财报数据显示,该股实现营业收入20.72亿美元,净利润4.18亿美元,每股收益5.97美元,毛利14.60亿美元,市盈率46.73倍。机构评级方面,在所有24家参与评级的机构中,83%的券商给予买入建议,17%的券商给予持有建议,无券商给予卖出建议。银休特股票所在的医疗器械行业中,整体跌幅为0.27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230435abdc865f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225230435abdc865f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4551","LU1119994496.HKD","LU0728928796.USD","BK4082","BK4588","LU1261432733.SGD","LU1084165304.USD","BK4585","BK4566","PODD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513756172","title":"银休特2024财年实现净利润4.18亿美元,同比增加102.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756172","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513756172?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326473,"startTime":"0","endTime":"0","summary":"2月24日,银休特公布财报,公告显示公司2024财年净利润为4.18亿美元,同比增加102.91%;其中营业收入为20.72亿美元,同比增加22.10%,每股基本收益为5.97美元。从资产负债表来看,银休特总负债18.76亿美元,其中短期债务83.80百万美元,资产负债比为1.65,流动比率为3.59。机构评级:截至2025年2月24日,当前有20家机构对银休特目标价做出预测,其中目标均价为319.85美元,其中最低目标价为280.00美元,最高目标价为355.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000145a250ce19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000145a250ce19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PODD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.insulet.com","stockEarnings":[{"period":"1week","weight":-0.0212},{"period":"1month","weight":0.0904},{"period":"3month","weight":0.0378},{"period":"6month","weight":-0.0496},{"period":"1year","weight":-0.547},{"period":"ytd","weight":-0.4846}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insulet Corporation是于2000年成立的一家特拉华州的公司。该公司主要从事开发、制造和销售其专有的胰岛素持续递送系统,用于胰岛素依赖型糖尿病患者。Omnipod平台包括:Omnipod 5自动胰岛素输送系统、Omnipod DASH胰岛素管理系统、Omnipod胰岛素管理系统和最新创新产品Omnipod GOTM,于2023年获得美国食品和药物管理局的许可。该公司还为安进生产Pods,用于Neulasta Onpro试剂盒,这是一种用于安进的Neulasta的递送系统,可帮助降低密集化疗后的感染风险。","yearOnYearQuotes":[{"month":1,"riseRate":0.578947,"avgChangeRate":-0.00575},{"month":2,"riseRate":0.421053,"avgChangeRate":-0.009473},{"month":3,"riseRate":0.631579,"avgChangeRate":0.000145},{"month":4,"riseRate":0.421053,"avgChangeRate":0.008173},{"month":5,"riseRate":0.421053,"avgChangeRate":0.017071},{"month":6,"riseRate":0.8,"avgChangeRate":0.048627},{"month":7,"riseRate":0.4,"avgChangeRate":-0.009556},{"month":8,"riseRate":0.75,"avgChangeRate":0.065205},{"month":9,"riseRate":0.5,"avgChangeRate":0.003911},{"month":10,"riseRate":0.55,"avgChangeRate":-0.002255},{"month":11,"riseRate":0.65,"avgChangeRate":0.077925},{"month":12,"riseRate":0.421053,"avgChangeRate":0.030709}],"exchange":"NASDAQ","name":"银休特","nameEN":"Insulet"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"银休特(PODD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供银休特(PODD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"银休特,PODD,银休特股票,银休特股票老虎,银休特股票老虎国际,银休特行情,银休特股票行情,银休特股价,银休特股市,银休特股票价格,银休特股票交易,银休特股票购买,银休特股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"银休特(PODD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供银休特(PODD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}